Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Aurinia Pharmaceuticals Inc. (AUPH)
Market Closed
1 Sep, 20:00
NASDAQ (NMS)
All
(5)
DE
(4)
US
(1)
NASDAQ (NMS)
Primary
XSTU
XMUN
XDUS
XFRA
$
16.
05
-0.06
-0.3724%
After Hours
$
16.
11
+0.06
+0.3738%
2.07B
Market Cap
-
P/E Ratio
-
Div Yield
878,722
Volume
-0.52
Eps
$
16.11
Previous Close
Investors:
BZ
ABB
LN
NA
+38
Watching
Watch
Add Transaction
Day Range
15.92
16.25
Year Range
10.34
19.25
Want to track
AUPH
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
News
Historical Data
Investors
Aurinia Pharmaceuticals Inc. (AUPH) Statistics
Valuation metrics
Market Cap
2.07B
Enterprise value
1.98B
Trailing P/E (ttm)
6.9
Forward P/E
-
PEG ratio
0.02
Price/Sales (ttm)
6.73
Price/Book (mrq)
3.45
Enterprise Value/Revenue
6.34
Enterprise Value/EBITDA
10.5
Overview
Shares outstanding
-
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
944.17K
Average volume (90 days)
1.38M
Price summary
52-Week low
10.34
52-Week high
19.25
Beta
-
50-Day moving average
15.72
200-Day moving average
15.45
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:50
Last split Date
23 Oct 2013
Financials
Fiscal year
Fiscal year ends
-
Most recent quarter (mrq)
-
Profitability
Profit margin
1.01%
Operating margin
0.48%
Operational effectiveness
Return on assets
0.4%
Return on equity
0.59%
Income Statement
Revenue (ttm)
-
Revenue per share (ttm)
2.39
Quarterly revenue growth (yoy)
-
Gross profit (ttm)
-
EBITDA
-
Net income to common (ttm)
-
Diluted EPS (ttm)
2.41
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
-
Total cash per share (mrq)
3.41
Total debt (mrq)
-
Total Debt/Equity (mrq)
0.1
Current ratio (mrq)
5.42%
Book value per share (mrq)
4.73
Cash Flow
Cash flow statement
-
Levered free cash flow (LFCF)
-